Evidence map›Paper›PMID 39384963›Full record

ArticleMolecular psychiatry2025

Sex/gender effects of glial reactivity on preclinical Alzheimer's disease pathology.

Clara Vila-Castelar, Muge Akinci, Eleni Palpatzis, Pablo Aguilar-Dominguez, Gregory Operto, Gwendlyn Kollmorgen, Clara Quijano-Rubio, Kaj Blennow, Henrik Zetterberg, Carles Falcon and 6 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Sex differences in Alzheimer's disease plasma biomarker levels and clinical utility.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  11. Sex and gender-related differences in neurological diseases: current challenges and recommendations for clinical practice.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Clara Vila-Castelar *Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA, 02114, USA.ORCID 0000-0002-8779-1487
Muge Akinci *Barcelona Institute for Global Health, IS GLOBAL, Carrer del Dr. Aiguader, 88, Ciutat Vella, 08003, Barcelona, Spain.
Eleni PalpatzisBarcelona Institute for Global Health, IS GLOBAL, Carrer del Dr. Aiguader, 88, Ciutat Vella, 08003, Barcelona, Spain.ORCID 0000-0001-8478-273X
Pablo Aguilar-DominguezBarcelona Institute for Global Health, IS GLOBAL, Carrer del Dr. Aiguader, 88, Ciutat Vella, 08003, Barcelona, Spain.
Gregory OpertoBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain.
Gwendlyn KollmorgenRoche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany.
Clara Quijano-RubioRoche Diagnostics International Ltd, Forrenstrasse 2, 6343, Rotkreuz, Switzerland.ORCID 0000-0001-9050-3282
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Wallinsgatan 6, 431 41, Mölndal, Sweden.ORCID 0000-0002-1890-4193
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Wallinsgatan 6, 431 41, Mölndal, Sweden.ORCID 0000-0003-3930-4354
Carles FalconBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain.ORCID 0000-0001-5564-2025
Karine FauriaBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain. kfauria@barcelonabeta.org.
Juan Domingo GispertBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain.ORCID 0000-0002-6155-0642
Oriol Grau-RiveraBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain.
Marc Suárez-CalvetBarcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Carrer de Wellington, 30, 08005, Barcelona, Spain.ORCID 0000-0002-2993-569X
Eider M Arenaza-UrquijoBarcelona Institute for Global Health, IS GLOBAL, Carrer del Dr. Aiguader, 88, Ciutat Vella, 08003, Barcelona, Spain. eider.arenaza@isglobal.org.ORCID 0000-0001-7016-7576
ALFA study

Funding

Examining the impact of sex and hormones on the progression of autosomal dominant Alzheimer's diseaseK99AG073452 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI VILA CASTELAR, CLARA · 2022 to 2023
$268k
Alzheimer's Association AARG 2019-AARG-644641Alzheimer's Association AARG 2019-AARG-644641-RAPIDEU Joint Programme - Neurodegenerative Disease Research (Programi i Përbashkët i BE-së për Kërkimet mbi Sëmundjet Neuro-degjeneruese) JPND2021-00694EU Joint Programme - Neurodegenerative Disease Research (Programi i Përbashkët i BE-së për Kërkimet mbi Sëmundjet Neuro-degjeneruese) JPND2022-138"la Caixa" Foundation (Caixa Foundation) 100010434Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI19/00155Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI22/00456NIA NIH HHS K99 AG073452U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) K99AG073452
6 · The paper itself

Abstract

Glial reactivity may contribute to sex/gender differences in Alzheimer's disease (AD) pathophysiology. Here, we investigated the differential effect of cerebrospinal fluid (CSF) glial markers on AD pathology and neurodegeneration by sex/gender among cognitively unimpaired older adults at increased risk of developing AD. We included 397 participants from the ALFA+ cohort with CSF Aβ

Indexed as

Alzheimer DiseaseNeurogliaAgedAged, 80 and overAmyloid beta-PeptidesBiomarkersChitinase-3-Like Protein 1Cohort StudiesFemaleGlial Fibrillary Acidic ProteinHippocampusHumansMagnetic Resonance ImagingMaleMembrane GlycoproteinsMiddle AgedAmyloid beta-PeptidesBiomarkersCHI3L1 protein, humanChitinase-3-Like Protein 1Glial Fibrillary Acidic ProteinMembrane GlycoproteinsPeptide FragmentsReceptors, Immunologictau ProteinsTREM2 protein, human

Identifiers

PMID39384963
PMCPMC11919761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.